FindTrial
Sign In

Hiberix

BIOLOGICAL7 trials

Sponsors

GlaxoSmithKline

Conditions

Acellular PertussisDiphtheriaHaemophilus Influenzae Type bHepatitis BInfections, MeningococcalInfections, StreptococcalPoliomyelitisRotavirus Infection

Phase 3

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine
CompletedNCT00344318
GlaxoSmithKlineInfections, Streptococcal
Start: 2006-08-07End: 2007-10-17Updated: 2018-12-07
Study to Assess Safety & Immunogenicity of GSK Biologicals' DTPa/Hib Vaccine vs Separate Administration of DTPa and Hib.
CompletedNCT00412854
GlaxoSmithKlineAcellular Pertussis, Diphtheria, Tetanus
Start: 2007-01-03End: 2007-06-25Updated: 2018-06-06
Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines
CompletedNCT00547248
GlaxoSmithKlineInfections, Streptococcal
Start: 2007-10-22End: 2008-10-07Updated: 2019-01-14
Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 10 Weeks of Age
CompletedNCT00814710
GlaxoSmithKlineInfections, Streptococcal, Streptococcus Pneumoniae
Start: 2009-03-07End: 2009-11-13Updated: 2020-01-03
Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants
CompletedNCT02096263
GlaxoSmithKlineAcellular Pertussis, Diphtheria, Haemophilus Influenzae Type b +3
Start: 2014-04-16End: 2015-11-13Updated: 2019-11-27
This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized Vaccine
CompletedNCT03207750
GlaxoSmithKlineRotavirus Infection, Rotavirus Vaccines
Start: 2017-09-14End: 2019-03-01Updated: 2020-12-29
Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants
CompletedNCT03621670
GlaxoSmithKlineInfections, Meningococcal
Start: 2018-07-27End: 2024-12-27Updated: 2026-02-10

Related Papers

408. Safety and Immunogenicity of Meningococcal Serogroup B Vaccine (4CMenB) and 13-Valent Pneumococcal Vaccine (PCV13) Administered Concomitantly with Routine Infant Vaccines (RIVs) to Healthy United States (US) Infants: A Randomized Controlled Study
Open Forum Infectious Diseases2026-01-01
Concomitant administration of a liquid formulation of human rotavirus vaccine (porcine circovirus-free) with routine childhood vaccines in infants in the United States: Results from a phase 3, randomized trial.
2020-10-172 citations
1385. Concomitant Administration of Liquid Porcine Circovirus-free Human Rotavirus Vaccine with Routine Pediatric Vaccines Does Not Impact Immune Responses in Infants: Results from a Phase 3, Randomized Trial in the United States
Open Forum Infectious Diseases2020-10-01
Immunogenicity and safety following primary and booster vaccination with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and <i>Haemophilus influenzae</i> type b vaccine: a randomized trial in the United States
Human Vaccines & Immunotherapeutics2018-11-2016 citations
Randomized, Open-Label Study of the Impact of Age on Booster Responses to the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine in Children in India
Clinical and Vaccine Immunology2014-07-109 citations
The 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) coadministered with DTPw-HBV/Hib and poliovirus vaccines: assessment of immunogenicity.
2009-04-0167 citations